Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma
出版年份 2018 全文链接
标题
Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-12-12
DOI
10.1038/s41416-018-0352-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
- (2018) Hailong Ma et al. BRITISH JOURNAL OF CANCER
- Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway
- (2018) Yingnan Wang et al. ORAL ONCOLOGY
- Targeting adenosine in cancer immunotherapy: a review of recent progress
- (2017) Theresa L Whiteside Expert Review of Anticancer Therapy
- Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma
- (2017) Hai-long Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma
- (2017) Manuela Silginer et al. NEURO-ONCOLOGY
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type I Interferon in Chronic Virus Infection and Cancer
- (2017) Laura M. Snell et al. TRENDS IN IMMUNOLOGY
- Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
- (2017) Marco Ruella et al. Cancer Discovery
- Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived Xenografts
- (2017) Shuyang Sun et al. Theranostics
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Interferon-α Promotes the Expression of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma
- (2017) Hailong Ma et al. Journal of Cancer
- Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
- (2017) Guillermo De Velasco et al. Cancer Immunology Research
- Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes
- (2016) Cherie T. Ng et al. CELL
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO
- (2016) Sijie Fang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma
- (2016) Hai-Long Ma et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma
- (2016) Francesco Sabbatino et al. JNCI-Journal of the National Cancer Institute
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
- (2016) Tanguy Y Seiwert et al. LANCET ONCOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma
- (2016) Francesco Sabbatino et al. JNCI-Journal of the National Cancer Institute
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency
- (2015) C. Liu et al. EMBO Molecular Medicine
- XL413, a cell division cycle 7 kinase inhibitor enhanced the anti-fibrotic effect of pirfenidone on TGF-β1-stimulated C3H10T1/2 cells via Smad2/4
- (2015) Shu-fang Jin et al. EXPERIMENTAL CELL RESEARCH
- Immunology and Immunotherapy of Head and Neck Cancer
- (2015) Robert L. Ferris JOURNAL OF CLINICAL ONCOLOGY
- Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue
- (2015) Stephanie Booy et al. PANCREAS
- IFNAR1 Is a Predictor for Overall Survival in Colorectal Cancer and Its mRNA Expression Correlated With IRF7 But Not TLR9
- (2015) Liang-Che Chang et al. MEDICINE
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
- (2014) Netanya G. Sandler et al. NATURE
- Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist
- (2014) D. Levin et al. Science Signaling
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation
- (2012) Jacob Piehler et al. IMMUNOLOGICAL REVIEWS
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway
- (2011) Jiao Chen et al. IMMUNOBIOLOGY
- IFN- Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity
- (2011) S. Terawaki et al. JOURNAL OF IMMUNOLOGY
- A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell Carcinoma
- (2011) Chien-Hua Peng et al. PLoS One
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity
- (2010) Paola Rizza et al. AUTOIMMUNITY
- Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
- (2009) Cherry L Estilo et al. BMC CANCER
- IFN-α wakes up sleeping hematopoietic stem cells
- (2009) Emmanuelle Passegué et al. NATURE MEDICINE
- Critical role for constitutive type I interferon signaling in the prevention of cellular transformation
- (2008) Hui-min Chen et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search